Your browser is no longer supported. Please, upgrade your browser.
BEAT BioTelemetry, Inc. monthly Stock Chart
BioTelemetry, Inc.
Index- P/E114.72 EPS (ttm)0.48 Insider Own2.89% Shs Outstand34.32M Perf Week12.26%
Market Cap1.87B Forward P/E26.68 EPS next Y2.08 Insider Trans0.00% Shs Float33.27M Perf Month32.85%
Income17.70M PEG4.59 EPS next Q0.48 Inst Own99.30% Short Float10.67% Perf Quarter39.99%
Sales438.80M P/S4.26 EPS this Y-31.60% Inst Trans3.13% Short Ratio10.92 Perf Half Y16.36%
Book/sh11.55 P/B4.80 EPS next Y20.13% ROA2.50% Target Price54.83 Perf Year19.65%
Cash/sh2.67 P/C20.71 EPS next 5Y25.00% ROE4.60% 52W Range27.35 - 55.85 Perf YTD19.68%
Dividend- P/FCF26.13 EPS past 5Y33.30% ROI7.60% 52W High-0.79% Beta1.27
Dividend %- Quick Ratio2.70 Sales past 5Y21.40% Gross Margin61.70% 52W Low102.60% ATR1.98
Employees1700 Current Ratio2.80 Sales Q/Q3.10% Oper. Margin9.20% RSI (14)77.84 Volatility4.22% 4.17%
OptionableYes Debt/Eq0.40 EPS Q/Q-19.70% Profit Margin4.00% Rel Volume1.34 Prev Close53.94
ShortableYes LT Debt/Eq0.40 EarningsOct 29 AMC Payout0.00% Avg Volume325.26K Price55.41
Recom2.00 SMA2015.58% SMA5021.81% SMA20027.54% Volume434,826 Change2.73%
Sep-11-20Initiated Needham Buy $52
Sep-02-20Initiated Robert W. Baird Neutral $43
Jan-08-20Initiated SunTrust Buy $58
Aug-02-19Downgrade Raymond James Outperform → Mkt Perform
Apr-26-19Reiterated Dougherty & Company Buy $81 → $75
Jul-26-18Reiterated Lake Street Buy $50 → $90
Apr-26-18Reiterated The Benchmark Company Buy $44 → $46
Feb-23-18Reiterated Dougherty & Company Buy $40 → $41
Nov-08-17Reiterated Dougherty & Company Buy $35 → $40
Oct-26-17Initiated Raymond James Outperform $37
Oct-24-17Initiated SunTrust Buy $41
Aug-09-17Reiterated Dougherty & Company Buy $37 → $40
Jul-19-17Reiterated The Benchmark Company Buy $38 → $44
Apr-11-17Reiterated Dougherty & Company Buy $30 → $37
Dec-02-16Initiated Dougherty & Company Buy $26
Sep-13-16Initiated Sidoti Buy
Aug-03-16Reiterated The Benchmark Company Buy $20 → $25
Jul-28-15Reiterated Dougherty & Company Buy $18 → $20
Oct-24-13Initiated The Benchmark Company Buy $15
Aug-21-13Initiated Dougherty & Company Buy
Nov-29-20 11:38PM  
Nov-13-20 08:15AM  
Oct-31-20 08:47AM  
Oct-30-20 03:01PM  
Oct-29-20 07:15PM  
Oct-28-20 10:14AM  
Oct-22-20 04:05PM  
Sep-14-20 09:27AM  
Sep-07-20 07:20AM  
Sep-02-20 10:20AM  
Aug-07-20 10:13AM  
Jul-31-20 03:01AM  
Jul-30-20 07:50PM  
Jul-29-20 08:00AM  
Jul-23-20 04:05PM  
Jul-05-20 02:45PM  
Jun-04-20 10:13AM  
May-07-20 04:01PM  
May-06-20 04:05PM  
May-01-20 06:40AM  
Apr-29-20 01:13PM  
Apr-27-20 09:05AM  
Apr-22-20 08:44AM  
Apr-16-20 12:31PM  
Apr-15-20 12:28PM  
Apr-07-20 10:29AM  
Mar-27-20 06:37AM  
Mar-25-20 09:21AM  
Mar-13-20 06:34AM  
Mar-11-20 06:25PM  
Feb-26-20 06:25PM  
Feb-19-20 12:31PM  
Feb-18-20 04:05PM  
Feb-13-20 12:31PM  
Feb-04-20 06:18AM  
Jan-12-20 08:18AM  
Dec-20-19 01:09PM  
Dec-11-19 12:16PM  
Nov-28-19 05:29AM  
Nov-12-19 09:05PM  
Nov-11-19 01:12PM  
Nov-05-19 07:05PM  
Nov-02-19 09:19AM  
Oct-29-19 02:54PM  
Oct-28-19 09:13AM  
Oct-07-19 08:07AM  
Sep-10-19 02:30PM  
Sep-03-19 04:05PM  
Aug-15-19 12:44PM  
Aug-05-19 12:07PM  
Aug-02-19 04:06PM  
Jul-30-19 10:24PM  
Jul-24-19 08:30AM  
Jul-23-19 10:32AM  
Jul-19-19 05:58PM  
Jul-18-19 09:58AM  
Jul-17-19 10:32AM  
Jul-16-19 02:24PM  
Jun-13-19 07:07AM  
Jun-04-19 07:30AM  
May-30-19 05:50PM  
May-25-19 09:15AM  
May-17-19 10:08AM  
May-15-19 01:52PM  
Apr-30-19 03:16PM  
Apr-29-19 01:22PM  
Apr-26-19 08:12AM  
Apr-25-19 05:26PM  
Apr-24-19 11:58AM  
Apr-23-19 08:49AM  
Apr-22-19 05:52PM  
Apr-18-19 05:45PM  
Apr-17-19 10:31AM  
Apr-12-19 10:32AM  
Apr-11-19 09:15AM  
Apr-08-19 09:30AM  
Apr-04-19 05:45PM  
Apr-01-19 02:38PM  
Mar-28-19 05:45PM  
Mar-21-19 05:45PM  
Mar-20-19 11:05AM  
Mar-18-19 11:18AM  
Mar-15-19 05:45PM  
Mar-08-19 08:58AM  
BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ferola PeterSVP & General CounselDec 31Option Exercise14.435,06573,08313,572Jan 06 07:42 AM
Ferola PeterSVP & General CounselDec 31Sale46.625,065236,1308,507Jan 06 07:42 AM